Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells.

Angelos MG, Ruh PN, Webber BR, Blum RH, Ryan CD, Bendzick L, Shim S, Yingst AM, Tufa DM, Verneris MR, Kaufman DS.

Blood. 2017 Jun 29;129(26):3428-3439. doi: 10.1182/blood-2016-07-730440. Epub 2017 May 22.

PMID:
28533309
2.

Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential.

Galat Y, Dambaeva S, Elcheva I, Khanolkar A, Beaman K, Iannaccone PM, Galat V.

Stem Cell Res Ther. 2017 Mar 17;8(1):67. doi: 10.1186/s13287-017-0519-0.

3.

T Cell Genesis: In Vitro Veritas Est?

Brauer PM, Singh J, Xhiku S, Zúñiga-Pflücker JC.

Trends Immunol. 2016 Dec;37(12):889-901. doi: 10.1016/j.it.2016.09.008. Epub 2016 Oct 24. Review.

PMID:
27789110
4.

Medial HOXA genes demarcate haematopoietic stem cell fate during human development.

Dou DR, Calvanese V, Sierra MI, Nguyen AT, Minasian A, Saarikoski P, Sasidharan R, Ramirez CM, Zack JA, Crooks GM, Galic Z, Mikkola HK.

Nat Cell Biol. 2016 Jun;18(6):595-606. doi: 10.1038/ncb3354. Epub 2016 May 16.

5.

In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination.

Smith MJ, Webber BR, Mohtashami M, Stefanski HE, Zúñiga-Pflücker JC, Blazar BR.

Stem Cells. 2015 Nov;33(11):3174-80. doi: 10.1002/stem.2115. Epub 2015 Aug 11. Review.

6.

Development of hematopoietic stem and progenitor cells from human pluripotent stem cells.

Chen T, Wang F, Wu M, Wang ZZ.

J Cell Biochem. 2015 Jul;116(7):1179-89. doi: 10.1002/jcb.25097. Review.

7.

Retinoic acid regulates hematopoietic development from human pluripotent stem cells.

Rönn RE, Guibentif C, Moraghebi R, Chaves P, Saxena S, Garcia B, Woods NB.

Stem Cell Reports. 2015 Feb 10;4(2):269-81. doi: 10.1016/j.stemcr.2015.01.009.

8.

Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co-express gamma and beta globins.

Yang CT, French A, Goh PA, Pagnamenta A, Mettananda S, Taylor J, Knight S, Nathwani A, Roberts DJ, Watt SM, Carpenter L.

Br J Haematol. 2014 Aug;166(3):435-48. doi: 10.1111/bjh.12910. Epub 2014 May 16.

9.

Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors.

Doulatov S, Vo LT, Chou SS, Kim PG, Arora N, Li H, Hadland BK, Bernstein ID, Collins JJ, Zon LI, Daley GQ.

Cell Stem Cell. 2013 Oct 3;13(4):459-70. doi: 10.1016/j.stem.2013.09.002.

10.

The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies.

Weinacht KG, Brauer PM, Felgentreff K, Devine A, Gennery AR, Giliani S, Al-Herz W, Schambach A, Zúñiga-Pflücker JC, Notarangelo LD.

Curr Opin Immunol. 2012 Oct;24(5):617-24. doi: 10.1016/j.coi.2012.07.001. Epub 2012 Jul 25. Review.

11.

Dynamic HoxB4-regulatory network during embryonic stem cell differentiation to hematopoietic cells.

Fan R, Bonde S, Gao P, Sotomayor B, Chen C, Mouw T, Zavazava N, Tan K.

Blood. 2012 May 10;119(19):e139-47. doi: 10.1182/blood-2011-12-396754. Epub 2012 Mar 21.

12.

Mechanisms of thymus organogenesis and morphogenesis.

Gordon J, Manley NR.

Development. 2011 Sep;138(18):3865-78. doi: 10.1242/dev.059998. Review.

13.

Comparative study of hematopoietic differentiation between human embryonic stem cell lines.

Melichar H, Li O, Ross J, Haber H, Cado D, Nolla H, Robey EA, Winoto A.

PLoS One. 2011;6(5):e19854. doi: 10.1371/journal.pone.0019854. Epub 2011 May 16.

14.

Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells.

Choi KD, Vodyanik M, Slukvin II.

Nat Protoc. 2011 Mar;6(3):296-313. doi: 10.1038/nprot.2010.184. Epub 2011 Feb 17.

15.

Dysregulated gene expression during hematopoietic differentiation from human embryonic stem cells.

Dravid G, Zhu Y, Scholes J, Evseenko D, Crooks GM.

Mol Ther. 2011 Apr;19(4):768-81. doi: 10.1038/mt.2010.281. Epub 2010 Dec 21.

16.

Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms.

Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS.

J Virol. 2011 Jan;85(1):43-50. doi: 10.1128/JVI.01774-10. Epub 2010 Oct 20.

17.

Pluripotent stem cell-derived natural killer cells for cancer therapy.

Knorr DA, Kaufman DS.

Transl Res. 2010 Sep;156(3):147-54. doi: 10.1016/j.trsl.2010.07.008. Epub 2010 Aug 1. Review.

18.

Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Kim YJ, Broxmeyer HE.

Crit Rev Oncol Hematol. 2011 Aug;79(2):112-26. doi: 10.1016/j.critrevonc.2010.07.009. Epub 2010 Aug 19. Review.

19.

Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.

Peters A, Burridge PW, Pryzhkova MV, Levine MA, Park TS, Roxbury C, Yuan X, Péault B, Zambidis ET.

Int J Dev Biol. 2010;54(6-7):965-90. doi: 10.1387/ijdb.093043ap. Review.

20.

Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis.

Plenge RM, Raychaudhuri S.

Rheum Dis Clin North Am. 2010 May;36(2):259-70. doi: 10.1016/j.rdc.2010.03.002. Review.

Supplemental Content

Support Center